tiprankstipranks
Trending News
More News >
Plus Therapeutics Inc (PSTV)
NASDAQ:PSTV
US Market
Advertisement

Plus Therapeutics (PSTV) Drug Pipeline

Compare
1,187 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
186Rnl
Leptomeningeal Metastasis
Phase I
Recruiting
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Jul 02, 2025
Rhenium-186 Nanoliposome
Ependymoma, High Grade Gliomas
Phase I
Not Yet Recruiting
Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma
May 03, 2025
Retreatment Rhenium Liposome
Glioma
Phase I
Recruiting
Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
Jun 13, 2022
186Rnl
Leptomeningeal Metastasis
Phase I
Active Not Recruiting
Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Aug 23, 2021
Rhenium Liposome Treatment
Glioma
Phase I/II
Recruiting
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
Jan 11, 2012

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Plus Therapeutics Inc (PSTV) have in its pipeline
      PSTV is currently developing the following drugs: 186Rnl, Rhenium-186 Nanoliposome, Retreatment Rhenium Liposome. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis